A detailed history of Hb Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hb Wealth Management, LLC holds 42,086 shares of AMGN stock, worth $11 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
42,086
Previous 41,703 0.92%
Holding current value
$11 Million
Previous $13 Million 4.07%
% of portfolio
0.15%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $118,492 - $129,216
383 Added 0.92%
42,086 $13.6 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $326,598 - $396,902
1,243 Added 3.07%
41,703 $13 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $1.08 Million - $1.31 Million
4,032 Added 11.07%
40,460 $11.5 Million
Q4 2023

Jan 16, 2024

SELL
$255.7 - $288.46 $339,313 - $382,786
-1,327 Reduced 3.51%
36,428 $10.5 Million
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $1.05 Million - $1.3 Million
4,801 Added 14.57%
37,755 $10.1 Million
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $430,254 - $508,766
2,008 Added 6.49%
32,954 $7.32 Million
Q1 2023

Apr 13, 2023

BUY
$225.79 - $275.2 $186,276 - $227,040
825 Added 2.74%
30,946 $7.48 Million
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $761,066 - $967,026
3,323 Added 12.4%
30,121 $0
Q3 2022

Oct 19, 2022

BUY
$224.46 - $253.15 $395,498 - $446,050
1,762 Added 7.04%
26,798 $6.04 Million
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $746,116 - $830,297
3,234 Added 14.83%
25,036 $6.09 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $2.1 Million - $2.32 Million
9,578 Added 78.35%
21,802 $5.27 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $2.43 Million - $2.78 Million
12,224 New
12,224 $2.75 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.